| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |